ATE412904T1 - Verfahren zur bestimmung von hepatitis c viren - Google Patents

Verfahren zur bestimmung von hepatitis c viren

Info

Publication number
ATE412904T1
ATE412904T1 AT99933204T AT99933204T ATE412904T1 AT E412904 T1 ATE412904 T1 AT E412904T1 AT 99933204 T AT99933204 T AT 99933204T AT 99933204 T AT99933204 T AT 99933204T AT E412904 T1 ATE412904 T1 AT E412904T1
Authority
AT
Austria
Prior art keywords
viruses
chv
hepatitis
determining hepatitis
determining
Prior art date
Application number
AT99933204T
Other languages
English (en)
Inventor
Katsumi Aoyagi
Chiharu Ohue
Kumiko Iida
Shintaro Yagi
Original Assignee
Advanced Life Science Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16683164&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE412904(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Advanced Life Science Inst Inc filed Critical Advanced Life Science Inst Inc
Application granted granted Critical
Publication of ATE412904T1 publication Critical patent/ATE412904T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT99933204T 1998-07-30 1999-07-30 Verfahren zur bestimmung von hepatitis c viren ATE412904T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21609498 1998-07-30

Publications (1)

Publication Number Publication Date
ATE412904T1 true ATE412904T1 (de) 2008-11-15

Family

ID=16683164

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99933204T ATE412904T1 (de) 1998-07-30 1999-07-30 Verfahren zur bestimmung von hepatitis c viren

Country Status (11)

Country Link
US (1) US7316905B1 (de)
EP (1) EP1020727B1 (de)
JP (1) JP3514729B2 (de)
KR (1) KR100847586B1 (de)
CN (1) CN1274424A (de)
AT (1) ATE412904T1 (de)
BR (1) BR9906660A (de)
CA (1) CA2305192C (de)
DE (1) DE69939811D1 (de)
ES (1) ES2313787T3 (de)
WO (1) WO2000007023A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6383740B2 (en) 1999-07-30 2002-05-07 Bioergonomics, Inc. Methods for simultaneously detecting both members of a binding pair
US6632601B2 (en) * 2000-06-15 2003-10-14 Chiron Corporation Immunoassays for anti-HCV antibodies
AU785380B2 (en) * 2001-03-28 2007-03-15 Ortho-Clinical Diagnostics, Inc. A hepatitis C antigen - antibody combination assay for the early detection of HCV infection
US7101683B2 (en) * 2001-06-26 2006-09-05 Abbott Laboratories Methods for the simultaneous detection of HCV antigens and HCV antibodies
JP4353793B2 (ja) * 2001-06-26 2009-10-28 アボット・ラボラトリーズ Ｈｃｖ抗原とｈｃｖ抗体との同時検出のための方法
US20030108563A1 (en) * 2001-11-07 2003-06-12 Chander Bahl Reagents for the simultaneous detection of HCV core antigens and antibodies
US7332269B2 (en) * 2001-11-11 2008-02-19 Ortho-Clinical Diagnostics, Inc. HCV core protein sequences
US20040152070A1 (en) * 2003-02-04 2004-08-05 Shah Dinesh O. Method of detection of HCV antibodies in combination assay or sole antibody assay
KR20070108284A (ko) * 2003-10-28 2007-11-08 가부시끼가이샤 센단세메이가가꾸겐큐죠 Ｃ형 간염 바이러스의 검출 방법
ATE493659T1 (de) * 2004-05-19 2011-01-15 Advanced Life Science Inst Inc Verfahren zum nachweis von hepatitis-b-virus
JP2009018990A (ja) * 2005-10-25 2009-01-29 Univ Kurume Ｃ型肝炎ウイルス由来ペプチド
GB0522193D0 (en) 2005-10-31 2005-12-07 Axis Shield Asa Method
ES2303496B1 (es) * 2008-02-21 2009-07-07 Fundacion Para El Estudio De Las Hepatitis Virales Metodo analitico perfeccionado para la deteccion de hepatitis c oculta, aplicaciones del mismo y su correspondiente kit de diagnostico.
FR2984328B1 (fr) 2011-12-20 2016-12-30 Bio-Rad Innovations Procede de detection d'une infection par le virus de l'hepatite c
MX2015012825A (es) 2013-03-14 2016-06-10 Abbott Lab Anticuerpos monoclonales del dominio de union de lipido del núcleo del virus de la hepatitis c vhc.
JP6505076B2 (ja) 2013-03-14 2019-04-24 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ Ｈｃｖ抗原−抗体組み合わせアッセイおよびこれに使用するための方法および組成物
JP2016512241A (ja) 2013-03-14 2016-04-25 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ 改良された抗体検出のためのｈｃｖｎｓ３組換え抗原およびこの突然変異体
US9891225B2 (en) 2013-05-10 2018-02-13 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Compositions and methods for simultaneous detection of HCV antigen/antibody
CN103630690B (zh) * 2013-12-17 2014-08-20 朱之炜 丙型肝炎病毒抗原抗体联合检测试剂盒及其检测方法
CN103675280B (zh) * 2013-12-17 2015-05-20 山东博科生物产业有限公司 一种检测丙肝核心抗原的标记物及试剂
CN104849460A (zh) * 2015-05-29 2015-08-19 山东博科生物产业有限公司 一种稳定的丙型肝炎病毒核心抗原酶结合物稀释液
JP6808178B2 (ja) * 2015-10-15 2021-01-06 富士レビオ株式会社 ヒトパルボウイルスｂ１９抗原および抗体の同時検出方法及びキット
JP2019523863A (ja) * 2016-05-31 2019-08-29 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ ウイルス抗原の血清学的検出方法
EP3465216B1 (de) * 2016-05-31 2020-04-08 Roche Diagnostics GmbH Vorbehandlungsverfahren zur schnellen erkennung von hcv-kernantigen
CN106093402A (zh) * 2016-05-31 2016-11-09 湖南康润药业有限公司 丙型肝炎病毒抗原抗体联合检测试剂盒
CN113552358B (zh) * 2021-09-03 2024-08-30 郑州安图生物工程股份有限公司 一种hcv病毒裂解剂及其制备方法、hcv病毒检测试剂盒

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148869A (en) 1975-03-06 1979-04-10 Baxter Travenol Laboratories, Inc. Immunological reagent and method of using same
CA1148859A (en) * 1979-06-14 1983-06-28 Lacy R. Overby Simultaneous assay of two hepatitis viruses using a solid phase
EP0131974A1 (de) * 1983-06-08 1985-01-23 Akzo N.V. Bestimmung von delta-Antigenen in Körperflüssigkeiten
JPH0610723B2 (ja) 1983-06-23 1994-02-09 コニカ株式会社 カラーネガフィルムの撮像装置
GB8317855D0 (en) * 1983-06-30 1983-08-03 Iq Bio Ltd Biochemical detection method
DE3327642A1 (de) * 1983-07-30 1985-02-14 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur bestimmung eines partners einer immunreaktion sowie reagens zur durchfuehrung dieses verfahrens
ZA855031B (en) * 1984-08-31 1986-02-26 New York Blood Center Inc Assay for simultaneous detection of antigen and antibody in given serum
JPS6415656U (de) 1987-07-17 1989-01-26
US5032503A (en) * 1988-06-22 1991-07-16 Microgenics Corporation Liquid single reagent for air enzyme complementation assay
CA1335880C (en) 1988-07-14 1995-06-13 Thomas P. O'connor Detection of an antibody and antigen in an immunoassay
JP3195799B2 (ja) 1990-12-20 2001-08-06 株式会社先端生命科学研究所 非ａ非ｂ型肝炎ウイルス構造蛋白質をコードするｄｎａ断片
CA2101056A1 (en) * 1991-01-25 1992-07-26 Adrienne L. Gilbert Use of superoxide dismutase in specimen diluent
US5574132A (en) * 1991-04-05 1996-11-12 Biochem Immunosystems Inc. Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
DE4209215A1 (de) * 1991-07-04 1993-01-07 Boehringer Mannheim Gmbh Hcv peptidantigene und verfahren zur bestimmung von hcv
US5525461A (en) * 1991-11-01 1996-06-11 T Cell Diagnostics, Inc. Therapeutic and diagnostic methods using total leukocyte surface antigens
WO1993021346A1 (en) 1992-04-09 1993-10-28 Abbott Laboratories Assay for detection of hiv antigen and hiv antibody
IT1257192B (it) * 1992-05-26 1996-01-10 Gilardini Spa Gruppo retrovisore per un veicolo.
JP2778886B2 (ja) * 1992-10-16 1998-07-23 エバーニュー バイオテック インコーポレイティド Ｃ型肝炎ウィルスのコア抗原タンパク質及びそれを用いての診断方法及びキット
JPH06300761A (ja) 1993-04-19 1994-10-28 Eiken Chem Co Ltd 免疫比濁測定試薬及び測定方法
US5843450A (en) * 1994-02-14 1998-12-01 Abbott Laboratories Hepatitis GB Virus synthetic peptides and uses thereof
JP3487643B2 (ja) * 1994-06-16 2004-01-19 アボットジャパン株式会社 特異的ＩｇＭ抗体の測定法及びその試薬
US5627080A (en) * 1994-07-29 1997-05-06 Beckman Instruments, Inc. Detergent-facilitated immunoassay for the rapid and quantitative assay of pharmacological agents
JPH0850133A (ja) 1994-08-05 1996-02-20 Toray Ind Inc 免疫化学的測定方法
US5616460A (en) * 1995-06-07 1997-04-01 Abbott Laboratories Buffer composition for reagents for immunoassay
GB2313666A (en) * 1996-05-28 1997-12-03 Hoffmann La Roche Assay for detecting HIV antigens and HIV antibodies
JP3171827B2 (ja) 1997-08-04 2001-06-04 株式会社先端生命科学研究所 ウイルスの検出又は測定方法
DE69837703T2 (de) * 1997-08-04 2008-01-10 Advanced Life Science Institute, Inc., Iruma Methoden zum nachweis und zur analyse von virus

Also Published As

Publication number Publication date
KR100847586B1 (ko) 2008-07-22
KR20010024340A (ko) 2001-03-26
ES2313787T3 (es) 2009-03-01
US7316905B1 (en) 2008-01-08
EP1020727A4 (de) 2004-12-29
EP1020727B1 (de) 2008-10-29
DE69939811D1 (de) 2008-12-11
JP3514729B2 (ja) 2004-03-31
CA2305192A1 (en) 2000-02-10
CA2305192C (en) 2009-10-13
WO2000007023A1 (fr) 2000-02-10
BR9906660A (pt) 2000-08-29
EP1020727A1 (de) 2000-07-19
CN1274424A (zh) 2000-11-22

Similar Documents

Publication Publication Date Title
DE69939811D1 (de) Verfahren zur bestimmung von hepatitis c viren
DE69735295D1 (de) Verfahren zur Aufkonzentrierung von Antikörperlösungen
ATE34848T1 (de) Verfahren zur bestimmung der low density lipoproteine (ldl) und reagenz zu seiner durchfuehrung.
DE69333289D1 (de) Verfahren zur bestimmung von säugetier nukleinsäuren aus stuhlproben und dafür benötigte reagenzien
CY1110549T1 (el) Ικριωματα πρωτεϊνων για μιμητικα αντισωματων και αλλες πρωτεϊνες συνδεσης
DE69802831D1 (de) Dynamisches heuristisches verfahren zur erkennung von computerviren
ATE112059T1 (de) Verfahren zur bestimmung eines analyten.
DE69020062D1 (de) Verfahren zur Bestimmung der Form einer Blende.
DE69230917D1 (de) Verfahren zur detektion von hepatitis c
DE69830556D1 (de) Verfahren zur Bestimmung von glykosylierten Proteinen
DE59609198D1 (de) Verfahren und Reagenz zur spezifischen Bestimmung von LDL in Serumproben
DE3787706D1 (de) Verfahren zur quantitativen Bestimmung der Antigene und Antikörper.
EP1308730A4 (de) Verfahren zum nachweis oder zum bestimmen von hbv
ATA96398A (de) Verfahren zur bestimmung von antigenen
DE68914252D1 (de) Verfahren zur Bestimmung eines Antigens.
ATE453724T1 (de) Verfahren zur bestimmung von löslichem fibrin
ATE465752T1 (de) Verfahren zur gewinnung delipidierter antigener aggregate von hepatitis b und deren verwendung
ATE292800T1 (de) Immunologische bestimmung des hydrophoben lungensurfaktantproteins sp-c
ATE153770T1 (de) Künstliche standard- und kontrollseren zur verwendung in verfahren zur bestimmung von antikörpern
DE69019810D1 (de) Verfahren zur optischen Bestimmung von Bilirubin und Reagenz dafür.
DE69919512D1 (de) Verfahren zur bestimmung von protheseinfektionen
EP1268749A4 (de) Diagnostische reagenzien und methoden für antikörper gegen hepatitis b oberflächenantigen und für antikörper gegen hepatitis b virus
DE69534877D1 (de) Verfahren zur bestimmung von bilirubin
ATE352785T1 (de) Verfahren zum nachweis von hepatitis c antigenen
DE69817449D1 (de) Verfahren und Reagenz zur Bestimmung von direktem Bilirubin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
REN Ceased due to non-payment of the annual fee